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Bacteria can have population structures ranging from
the fully sexual to the highly clonal. Despite numerous





 is still somewhat contentious. We used a
polyphasic approach in order to shed new light on
this issue. A data set consisting of three outer mem-












), a DNA-based fingerprint (amplified fragment





 clinical and environmental iso-
lates, collected across the world, was analysed using
biological data analysis software. We observed a clear
mosaicism in the results, non-congruence between
results of different typing methods and a microscale




 gene. Hence, in this
network, we also observed some clonal complexes
characterized by an almost identical data set. The
most recent clones exhibited serotypes O1, 6, 11 and
12. No obvious correlation was observed between
these dominant clones and habitat or, with the excep-
tion of some recent clones, geographical origin. Our
results are consistent with, and even clarify, some
seemingly contradictory results in earlier epidemio-
logical studies. Therefore, we suggest an epidemic










clonal structure with frequent recombinations, in






 is noted for its metabolic ver-
satility and its exceptional ability to adapt to and colonize
a wide variety of ecological environments (water, soil,
rhizosphere, animals) (Goldberg, 2000). It is also known
for its capacity to cause disease in cystic fibrosis, burn,





 are difficult to treat because of
its inherent resistance to antibiotics. There seems to be





isolates are genotypically, chemotaxonomically and func-





. (1994) reported that the most frequently
(28%) identified clone in cystic fibrosis patients was also
detected at a relatively high frequency (21%) in aquatic
environments, suggesting a common recent origin of




. (1995) demonstrated the













strains isolated from a gasoline-contaminated aquifer
were indistinguishable, by molecular biological tech-










 show pathogenic and biodegrada-



















 was panmictic, but highlighted
the need for caution in inferring bacterial population struc-
ture from any single class of genetic marker. Comparative




 isolates revealed a high frequency of
recombination and a net-like population structure (Kiewitz




. (2001) used random-
amplified polymorphic DNA (RAPD) typing to study the





aemia and environmental isolates. They concluded that
















the studied population underwent epidemic clonality with
a high rate of genetic recombination and that bacteraemia





. (2001) observed an epidemic





lated mainly from patients with keratitis and their environ-
ment. They found evidence for an epidemic clone that is
pathogenic to the eye and is characterized by a distinct
combination of virulence factors. The above-mentioned




 populations were often sampled in a rela-
tively small region (mainly one country) and/or focused on
a single pathology or specific environment and/or were
analysed by only one method. With the call of van Belkum




., 1996) for a polyphasic
approach in mind, we integrated all phenotypic and geno-
typic data available to us in a consensus type of clustering





. A data set, consisting of the nucle-













), amplified fragment length polymor-
phism (AFLP) pattern analysis, serotype and pyoverdine














 (504 bp) genes are
















 gene is conserved among the fluorescent
pseudomonads and was found to be useful as a comple-
mentary phylogenetic marker for the classification of rRNA












 and has proved to be


















 gene (1323 or 1329 bp) codes for
a specialized pore protein, OprD, which allows selective
permeation of basic amino acids and their structural ana-
logues such as the carbapenem antibiotic imipenem (Trias




 gene from 55
clinical and environmental isolates revealed important
sequence variability and a microscale mosaic structure





AFLP analysis is a genotyping method based on the
selective amplification of a subset of DNA fragments gen-





This technique has proved to be highly discriminatory and
reproducible, which allows the compilation of standard-













 strains have been divided
into serotypes since 1926 (Aoki, 1926). Since then, many
investigators have formed their own serotyping schemata,










1983), most European and American researchers have





, comprising 17 groups based on the heat-stable





 strains, using this standardized
schema, allows us to compare the evolutionary relation-
ships between our isolates, provided by the two DNA-
based techniques, with earlier published epidemiological
data.
To satisfy their need for iron, pseudomonads generally
produce high-affinity fluorescent peptidic siderophores,





, three PVDs (I, II and III), easily differentiated by
isoelectric focusing (IEF), have been observed so far, only









., 1997). The combined results obtained
in this study are in agreement with earlier epidemiological












































. Alleles were assigned numbers according to their









showed sequence variability comparable with that of
housekeeping genes, as was to be expected because both


















tion, supplemented with other members of the rRNA group




 forms a sharply
delineated species. Strains LMG 10643 and, to a lesser
extent, strains LMG 5031 and Br680 diverge from the rest.








 were silent, often occurring at the third




 gene, on the other hand,
showed high sequence variability, a mosaic structure and
multiple non-silent mutations, typical of a gene that is





of strains LMG 10643 and Lw1048 could not be amplified












 strain were normalized



































., 1995), five clusters of









Sixty-one out of the 73 strains could be serotyped. Six
strains were non-agglutinable, and six were polyagglutin-
able. The predominant serotypes were O1 (12.3%, 9/73),
6 (10.9%, 8/73), 11 (15.1%, 11/73) and 12 (9.6%, 7/73)
(Table 1).
 
Pyoverdine typing by IEF
 




 strains (37/73) produced
or were growth stimulated by type II PVD (Table 1). Fifteen
isolates produced type I PVD and 14 type III. A few iso-
lates failed to produce enough PVD to allow analysis by
IEF. The presence of the receptor for a pyoverdine was
therefore determined by a growth stimulation assay. In
some cases, growth was stimulated by more than one
PVD (Table 1). When this was the case, the pyoverdine
that gave the strongest growth stimulation was considered





The data obtained from sequence analysis, AFLP analy-








biological data analysis software. In the dendrogram from
the composite data set (Fig. 4), we identified a limited





Some subclusters even showed >90% similarity. We also
observed unique isolates, some of which diverged consid-
erably from the rest of the population. There is also evi-
dence that the relation among the isolates was distorted
by recombination. We observed a network of relationships
between all analysed parameters (Table 1) and non-




The observation of clones in many bacterial populations
has led to the assumption that bacteria reproduce clonally.
It was long supposed that point mutations are the major
source of genetic variation in bacteria, whereas recombi-
national exchanges were considered to be rare. This view
has changed in recent years. Maynard Smith et al. (1993)
used multilocus enzyme electrophoresis (MLEE) to dem-
onstrate that bacterial population structure ranges from
the panmictic or fully sexual, with random association
between loci (e.g. Neisseria gonorrhoeae), to one that is
clonal, with non-random association of alleles, resulting in
the frequent recovery of only a few of the possible multilo-
cus genotypes (e.g. Salmonella enterica). Intermediate
types of population structure were also reported. Neisseria
meningitidis, for example, displays what the authors have
called an ‘epidemic’ structure. Although the population is
sexual in the long term, some epidemic clones show
significant association between loci. Recently, Feil et al.
(2001) used multilocus sequence typing (MLST) (Maiden
et al., 1998) to examine the extent and significance of
recombination in six bacterial pathogens. In four species
(N. meningitidis, Streptococcus pneumoniae, Streptococ-
cus pyogenes and Staphylococcus aureus), they observed
a lack of congruence between gene trees, supported by
high ratios of recombination to point mutation. In contrast,
for Haemophilus influenzae and pathogenic isolates of
Escherichia coli, there was some congruence between
gene trees, suggesting lower rates of recombination.
In this work, data obtained by four different typing meth-
ods, performed on a large batch of unrelated clinical and
environmental P. aeruginosa isolates, are combined using
biological data analysis software in order to get some
insights into the population structure of P. aeruginosa.
The lack of congruence among experiments (Fig. 5) is
most easily explained as the consequence of multiple
recombinational events that have eliminated the phyloge-
netic signal in each tree. This view is supported by the
observation of a microscale mosaic structure in the oprD
gene (Fig. 1), which supplies direct evidence for recombi-
nation. The non-congruence between the AFLP dendro-
gram and the trees based on sequence analysis could be
expected, as sequence diversity is generally caused by
single nucleotide polymorphisms, whereas differences in
macrorestriction fragment patterns are mainly the result of
insertions and/or deletions (Kiewitz and Tümmler, 2000).
Although bacterial species in which recombination
appears to be common are naturally transformable, there
seems to be no obvious correlation between the degree
of recombination and the transformability of species. Feil
et al. (2001) showed that the naturally transformable H.
influenzae showed by far greater congruence between
gene trees than the non-transformable species S.
aureus and S. pyogenes. They suggested that recombina-
tional exchanges in S. aureus and S. pyogenes are pre-
sumably mediated by phage transduction, the effect of
which is as great as that of transformation. P. aeruginosa
is considered not to be competent for natural transforma-
tion. In this context, it is interesting that Ripp et al. (1994)
suggested that environmentally endemic bacteriophages
are formidable transducers of naturally occurring microbial
communities of P. aeruginosa.
Hence, the population structure of P. aeruginosa is not
fully sexual. In the dendrogram based on the comparison
of the composite data set (Fig. 4), we clearly observed
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Fig. 1. Polymorphic sites detected in the different alleles of the oprI, oprL and oprD genes of 73 P. aeruginosa isolates. Only the sites that differ 
from the sequence of the allele of PAO1 (no. 23) are shown. Alleles are arranged according to their positions in the dendrogram of an UPGMA 
alignment. The number of representatives for each allele is shown on the right. Defective oprD mutations and alleles with unusually high sequence 
variability are excluded. Gaps are represented by *.
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Fig. 1. cont.
seven distinct clonal complexes (CCs) with ≥80% similar-
ity. Most CCs contain strains from geographically and
ecologically different sites, suggesting high rates of migra-
tion and a remarkable nutritional versatility, acquired
through recombination or another evolutionary mecha-
nism. CC A, for example, contains a blood, wound and
urine isolate from three distant cities in the USA, a blood
isolate from Congo, a sputum, throat and plant rhizo-
sphere isolate from Belgium and a burn wound isolate
from Turkey. The variability within each geographic region
was nearly as great as within the whole population. In
Belgium and The Netherlands, for example, members of
CCs A, B, C, E, F and G were isolated.
Clones are transient and, over time, recombination will
obliterate the evidence of association. The nearly identical
data set of the members of subclusters a, c, d, e and g
(Table 1), resulting in ≥90% homology in the composite
data dendrogram (Fig. 4), is evidence of a recent, explo-
sive increase in these clones. These recent clones exhibit
serotypes O1, 6, 11 and 12. This observation is in agree-
ment with earlier epidemiological studies. A study of the
serotypes of 2952 P. aeruginosa isolates showed a
predominance of serotypes O1, 6 and 11 (Bert and
Lambert-Zechovsky, 1996), and serotypes O11 and 12
are frequently associated with multidrug-resistant epi-
demic strains (Farmer et al., 1982; Grattard et al., 1993;
Elaichouni et al., 1994; Richard et al., 1994; Tassios et al.,
1998; Dubois et al., 2001). Serotyping of 7089 P. aerugi-
nosa strains, isolated in 16 Belgian hospitals in the period
from 1977 to 1986, revealed a steady increase in P. aerug-
inosa O12 isolates from 2% in 1982 to 22% in 1986
(Allemeersch et al., 1988). The majority of these O12 iso-
lates showed the same distinctive pyocin and phage
types, suggesting a high degree of homogeneity within the
O12 strains in Belgium. A multicentre European study
provided evidence for a common O12 P. aeruginosa strain
in Europe (Pitt et al., 1989). Yet, not all O12 isolates
belong to clone c. Serotype O12 clinical isolates Bo546
and Br680 are positioned far away from clone c in the
composite data dendrogram (Fig. 4). Evidence of geno-
typic heterogeneity among P. aeruginosa serotype O12
outbreak isolates has been reported (Bingen et al.,
1996).
Although CCs are globally distributed, recent clones
are, logically, less widespread (Table 1). Clone d, for
example, consists of 10 isolates of a major clone (called
clone C) common to patients and aquatic environments
in Germany, previously identified by Römling et al. (1994).
The occasional clustering of strains of distant geogra-
phical origin in recent clones (e.g. strain PAO29 in clone
c) illustrates the efficient dispersal of P. aeruginosa
clones, probably aided by increased mobility of the human
population.
The close genetic relation among the isolates of each
clone was also detected by AFLP analysis. This shows
that AFLP can be used, for example in clinical settings, to
recognize epidemic P. aeruginosa clones over the short
term (10 to maybe hundreds of years).
No significant correlation could be made between the
type of PVD produced and the habitat. Recently, De Vos
et al. (2001) reported a prevalence of type II PVD isolates
in cystic fibrosis patients, but suggested that their might
be a correlation between the pyoverdine type and the
(clinical) origin of the P. aeruginosa isolates. The fact that
several P. aeruginosa strains are able to use more than
one PVD type (Table 1) could be the result of recombina-
tional events involving PVD receptors. Strain LMG 10643
did not produce, nor was able to use, any of the three
PVDs. This, together with the aberrant oprI and oprL
sequences, makes us doubt that this isolate is a true P.
aeruginosa. The clustering of isolates with different sero-
types is not necessarily the result of recombinational
events. Kobayashi et al. (1994) demonstrated that anti-
pseudomonal drugs were able to induce changes in sero-
type, and possible evidence of a bacteriophage-mediated
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Fig. 2. Sequence similarity trees (UPGMA) based on the comparison of the oprI and oprL nucleotide sequences of the 73 studied P. aeruginosa 
isolates, supplemented with members of the rRNA group I pseudomonads. Sequences of P. aeruginosa and P. pseudoalcaligenes isolates were 
determined in this study, P. fluorescens (pf0-1), P. syringae (pv. tomato) and P. putida (KT2440) sequences were retrieved from the unfinished 
genomic sequence database (http://www.ncbi.nlm.nih.gov/cgi-bin/Entrez/genom_table_cgi) using BLASTN software; all other sequences were 
retrieved from the NCBI GenBank (http://www.ncbi.nlm.nih.gov/). Percentages of similarity are shown above the dendrogram.
serotype O5 to O16 conversion (Newton et al., 2001) was
found in the clustering of reference strain PAO1 and strain
LMG 14083 in CC B (Fig. 4).
Not that long ago, the ability to identify clusters of iso-
lates with an identical data set from different countries and
habitats over a period of time would have been taken as
evidence of a clonal structure. The multiple associations
of serotypes O11 and 12 with infection and epidemics and
the frequent recovery of only a few of all the possible
serotypes (O1, 6 and 11) superficially suggest that the P.
aeruginosa population is clonal. Our results show an epi-
demic population structure for P. aeruginosa, comparable
with that of N. meningitidis (Feil et al., 2001), a population
composed of a limited number of widespread clones,
which originated, through selection, from a background
of a large number of relatively rare and unrelated geno-
types that are recombining at a high frequency. These
adaptive clones are abundant and widespread in nature
and are therefore expected to predominate in the patient
population.
Future investigations should be directed at factors that
play a role in the selective advantages of these highly
successful clones in the environment as a whole, instead
of restricting analysis to patients and the hospital environ-
ment. The cause of the association between virulence and
fitness is still unclear (Groisman and Ochman, 1994).
It should be noted that MLST focuses exclusively on
housekeeping genes because of selective neutrality. Anal-
ysis of these genes provides a more realistic impression
of the effect of recombination. In contrast, oprD recombi-
nants can be selectively favoured if, for example, they
confer resistance to carbapenem antibiotics. However, we
chose to include the oprD sequence data for the following
reasons: (i) OprD-related resistance to carbapenems is
mainly achieved by non-recombinational events such as
point mutations (Pirnay et al., 2002); (ii) it provides direct
904 J.-P. Pirnay et al.
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Fig. 3. Normalized AFLP patterns and dendrogram for 73 different P. aeruginosa isolates and one P. pseudoalcaligenes isolate (Br780). Cluster 
analysis was performed with BIONUMERICS software using the Pearson correlation and UPGMA. Percentages of similarity are shown above the 
dendrogram. Clusters with ≥80% similarity (according to Tenover et al., 1995; Speijer et al., 1999) are indicated by Roman numerals. Clusters I, 
II and III contain isolates with slightly <80% homology.
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evidence for localized recombination in P. aeruginosa; and
(iii) despite the high sequence variability, members of
recent clones show identical oprD sequences, thus illus-
trating the stability of these clonal complexes. Although
we did not perform conventional MLST, we feel that there
is sufficient justification for concluding that P. aeruginosa
displays an epidemic population structure. A more
detailed and prospective study involving more clinical and
environmental isolates from other parts of the world, as
well as housekeeping gene sequence data, is currently
under way. We also feel that the exchange of standardized
data between laboratories and the creation of interna-
tional reference databases of typed microorganisms
should be encouraged. It will enable the efficient monitor-
ing of changes in microbial populations.
Experimental procedures
Bacterial strains and growth conditions
A total of 73 P. aeruginosa clinical and environmental iso-
lates, collected worldwide, mainly in the late 1980s and
1990s, with some earlier isolates, were examined. The geo-
graphical origin, isolation site and time of all P. aeruginosa
isolates are listed in Table 1.
The P. aeruginosa strains used in this study were kindly
provided by: Dr A. T. McManus, US Army Institute of Surgical
Research, TX, USA; Dr L. Ménesi, General Hospital St
Istvan, Budapest, Hungary; Dr A. Vanderkelen, Queen
Astrid Military Hospital, Neder-Over-Heembeek, Belgium;
Dr J. A. Clark, Queen Mary's University Hospital, London,
UK; Dr A. F. Vloemans, Rode Kruis Ziekenhuis, Beverwijk,
The Netherlands; Dr T. Taddonio, University of Michigan, MI,
USA; Dr A. Radke, Klinik für Verbrennungs- und Plastische
Wiederherstellungschirurgie, Aachen, Germany; Professor
R. Konigova, Charles University Hospital, Prague, Czech
Republic; Dr R. G. Tompkins, Burns Institute, Shriners
Hospital for Children, Boston, MA, USA; Dr B. Tümmler,
Medizinische Hochschule, Hannover, Germany; Dr M.
Caneira, Hospital de Santa Maria, Lisbon, Portugal; Profes-
sor A. Boudabous, Science Faculty, Tunis, Tunisia; Dr M.
Mergeay, Environmental Technology Expertise Centre, Mol,
Belgium; Dr A. E. Lim, Jr., St Scholastica's College of Health
Sciences, Tacloban City, Philippines; Professor O. Hadjiiski,
Scientific Institute of Emergency Medicine Pirogov, Sofia,
Bulgaria; Professor K. Taviloglu, University of Istanbul,
Istanbul, Turkey; Dr W. D. H. Hendriks, Zuiderziekenhuis,
Rotterdam, The Netherlands; Dr G. Wauters, University of
Louvain, Brussels, Belgium; Dr O. Vandenberg, Universitair
Ziekenhuis St-Pieters, Brussels, Belgium. Strain PAO-1 was
kindly provided by Dr C. K. Stover (PathoGenesis Corpora-
tion, Seattle, WA, USA). Strain ATCC 27853 was purchased
from Gibson Laboratories. P. aeruginosa strains LMG 2107,
5031, 10643 and 14083–5 and P. pseudoalcaligenes strains
LMG 1225, 2854, 5516, 5517 and 6036 were purchased
from the BCCM/LMG bacteria collection. Unless otherwise
indicated, strains were grown on Luria–Bertani broth medium
(Gibco BRL Life Technologies) at 37°C on a rotary shaker
(150 r.p.m.).
PCR and sequencing of the oprI, oprL and oprD genes
DNA was extracted from overnight P. aeruginosa cultures
using the High Pure™ PCR template preparation kit (Roche
Diagnostics) according to the manufacturer's guidelines.
The oprI, oprL and oprD genes were amplified by PCR,
using the primers described in Table 2. PCR was performed
in 200 µl microcentrifuge tubes. The PCR mixture (50 µl final
volume) contained the following: 25.5 µl of sterile distilled
water, 5 µl of 10× PCR buffer (500 mmol l−1 KCl and
100 mmol l−1 Tris-HCl, pH 8.3), 4 µl of a deoxynucleotide mix-
ture (dGTP, dTTP, dATP and dCTP; 2 mmol l−1 each), 5 µl of
MgCl2 (2.5 mmol l−1), 5 µl of a primer mixture (PS1/2 for oprI,
PAL1/2 for oprL or pDF1/R1 for oprD; 10 µmol l−1 each), 5 µl
of template DNA and 0.5 µl of AmpliTaq DNA polymerase
(5 U µl−1). All PCR reagents and primers were ordered from
PE Applied Biosystems. The amplification was performed in
a GeneAmp® PCR system 2400 (PE Applied Biosystems).
The amplification programme was set at 50 cycles of dena-
turation at 94°C for 30 s, annealing at 50°C or 57°C, accord-
ing to the primers (Table 2), for 30 s and elongation at 72°C
for 1 min. For the amplification of P. pseudoalcaligenes oprL
genes, the annealing temperature was lowered to 55°C. The
reaction mixture was put on a 1.5% (w/v) agarose gel for
electrophoresis and visualization of the PCR product after
staining with ethidium bromide on a transilluminator. The
DNA bands corresponding to the amplified oprI, oprL and
oprD genes were excised from the agarose gel with a clean
scalpel. DNA was extracted from the gel slice using the
QIAEX II gel extraction kit (Westburg) according to the man-
ufacturer's recommendations. Purified PCR fragment (5 µl)
was used as a template in the sequencing reaction. PCR
primers were used for sequencing. Sequencing of the coding
and anticoding strand of the oprD PCR products necessitated
two additional internal primers, pDF2 and pDR2 (Table 2).
DNA sequencing used an ABI 377 automated fluorescence
sequencer (PE Applied Biosystems) and the ABI Prism®
BigDye™ Terminator cycle sequencing ready reaction kit (PE
Applied Biosystems) as detailed in the manufacturer’s proto-
cols. The oprD gene of isolate Be128 was sequenced directly
from genomic DNA. PCR and sequencing were performed in
duplicate in order to be able to detect eventual PCR mistakes.
Sequences were aligned and clustered using the unweighted
pair group method using arithmetic averages (UPGMA) and
BIONUMERICS software (Applied Maths).
AFLP
AFLP used an ABI 377 automated fluorescence sequencer
(Applied Biosystems) and the AFLP microbial fingerprinting
kit (Applied Biosystems) as detailed in the manufacturer’s
protocols. The enzymes used were T4 DNA ligase, EcoRI
and Tru9I (all purchased from Roche Diagnostics). The
primer pair used was EcoRI-0[FAM]/MseI-C. GeneScan-
500[ROX] internal standard (Applied Biosystems) was co-
electrophoresed with each sample in order to allow an
accurate calculation of fragment lengths and correction for
variation rates and gel distortions. Normalization and frag-
ment sizing were carried out using GENESCAN software
(Applied Biosystems). Band patterns were imported into
BIONUMERICS software for further normalization (background
906 J.-P. Pirnay et al.
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subtraction, filtering: arithmetic average and band search:
minimum profiling 0.5% relative to maximum value) and clus-
ter analysis (similarity coefficient: Pearson correlation, den-
drogram type: UPGMA, optimization: 0%, position tolerance:
1%, uncertain bands were ignored).
Serotyping
Isolates were serotyped by slide agglutination according to
the international serogrouping schema for P. aeruginosa (Liu
et al., 1983), using a panel of 16 type O monovalent antisera
(Sanofi Diagnostics Pasteur).
Pyoverdine typing by IEF
PVD-IEF was carried out according to the method developed
by Koedam et al. (1994), as described previously (Meyer
et al., 1997). IEF was performed on Ampholine-PAG plates
(pH 3.5–9.5; Pharmacia). The following reference strains
were included: PAO-1, representative of PVD type I; ATCC
27853, representative of PVD type II; and strain Pa6, a clin-
ical isolate representing PVD type III (Meyer et al., 1997).
Pyoverdine typing by PVD-induced growth stimulation
The effect on bacterial growth of each of the three known
PVDs was tested as described previously (Meyer et al.,
1997). Casamino acid agar (CAA) plates (Cornelis et al.,
1992) supplemented with 0.5 mg ml−1 ethylenediaminedihy-
droxyphenylacetic acid (EDDHA) were homogeneously inoc-
ulated with 100 µl of a 1:10 diluted overnight bacterial culture
at 37°C in CAA medium. Sterile filter paper disks (6 mm
antibiotic disks; Institut Pasteur Productions) were impreg-
nated with 20 µl of each filter-sterilized 1 mM aqueous solu-
tion of pyoverdine and placed on the surface of the agar.
Plates were incubated at 37°C and scored after 24 h: no
stimulation (no growth), slight stimulation (growth, diameter
<10 mm) and good stimulation (thick growth, diameter
>15 mm). Pyoverdines produced by the type strains PAO1
(PVD type I), ATCC 27853 (PVD type II) and Pa6 (PVD
type III) were purified as described previously (Meyer et al.,
1997).
Data analysis
The entire data set, consisting of oprI, oprL and oprD
sequences, AFLP pattern, serotype and pyoverdine type of
73 P. aeruginosa isolates, was analysed and combined using
BIONUMERICS (Applied Maths) biological data analysis soft-
ware. Similarity values were taken from the individual exper-
iments and multiplied by weights (AFLP: 35, oprD: 11, oprL:
6, serotype: 5, oprI: 2, and PVD type: 1). These weights were
an educated guess and designed to compensate for the bias
caused by the differences in discriminatory capacity between
the experiments in this study. In other words, the weights are
proportional to the supposed discriminatory capacity of the
different typing methods. A dendrogram from the composite
data set was obtained using UPGMA. Congruence between
experiments was calculated using the Pearson product-
moment correlation coefficient.
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Table 2. Primers for PCR and sequencing.
Primer Gene Sequence (5′ to 3′) Temp. (°C)
PS1 oprI ATGAACAACGTTCTGAAATTCTCTGCT 57
PS2 oprI CTTGCGGCTGGCTTTTTCCAG 57
PAL1 oprL ATGGAAATGCTGAAATTCGGC 57
PAL2 oprL CTTCTTCAGCTCGACGCGACG 57
pDF1 oprD ATGAAAGTGATGAAGTGGAGC 50
pDF2 oprD AACCTCAGCGCCTCCCT 50
pDR1 oprD CAGGATCGACAGCGGATAGT 50
pDR2 oprD AGGGAGGCGCTGAGGTT 50
Fig. 4. Dendrogram (UPGMA) based on the comparison of the composite data set consisting of oprI, oprL and oprD nucleotide sequences, AFLP 
pattern, serotype and pyoverdine type of 73 P. aeruginosa isolates. Letters indicate clusters or clonal complexes with ≥80% (caps) and subclusters 
with ≥90% similarity. Some clusters contain isolates with slightly less homology. Percentages of similarity are shown above the dendrogram.
Fig. 5. Matrix of congruence values (percentages) between dendro-
grams based on the comparison of oprI, oprL and oprD sequences 
and AFLP patterns, and a dendrogram derived from that matrix. The 
congruence between experiments was calculated using the Pearson 
product-moment correlation coefficient.
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at the Pseudomonas 2001 conference, Brussels, Belgium,
September 17–21.
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